G. Anderson (Parkville, Australia), P. Corris (Newcastle-Upon-Tyne, United Kingdom), T. Maes (Gent, Belgium)
LATE-BREAKING ABSTRACT: Umeclidinium (GSK573719) dose response and dosing interval in COPD
A. Church, M. Beerahee, J. Brooks, R. Mehta, P. Shah (Durham, United States Of America; Stevenage, Uxbridge, United Kingdom)
|  |
LATE-BREAKING ABSTRACT: Apolipoprotein A1 (ApoA1) abrogate cigarette smoke induced emphysema in mice
D. Kim, S. Park, J. J. Shim (Bucheon, Seoul, Republic Of Korea)
| |
LATE-BREAKING ABSTRACT: Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in patients with persistent asthma: A 24-week randomised trial
J. Lötvall, E. Bleecker, W. Busse, P. O‘Byrne, A. Woodcock, E. Bateman, E. Kerwin, S. Stone, R. Forth, L. Jacques (Gothenburg, Sweden; Winston-Salem, Madison, Medford, Durham, United States Of America; Hamilton, Canada; Manchester, Uxbridge, United Kingdom; Cape Town, South Africa)
| |
LATE-BREAKING ABSTRACT: RC kinase: A novel kinase expressed by alveolar macrophages that may play a role in COPD and IPF
S. Boehme, J. Ludka, D. DiTirro, A. L. Coelho, C. Hogaboam, T. W. Ly, K. Bacon (San Diego, Ann Arbor, United States Of America)
|  |
Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation
J.F. Xu, G.R. Washko, H.P. Li, A.M.K. Choi, G.M. Hunninghake (Shanghai, China; Boston, United States Of America)
| |
Effects of combination of PI3Kγ and δ inhibitors on airway hyperresponsiveness in tobacco smoke-exposed mice
Y. Kizawa, G. Kimura, K. Ueda, Y. Watanabe, S. Eto, T. Kusama, K. Ito (Funabashi, Japan; London, United Kingdom)
| |
A robust translational model of acute exacerbations in the tobacco-smoke and poly IC treated mouse
V. Russell, P. Woodman, A. Connolly, D. Spicer, J. Dlugozima, A. Young (Slough, United Kingdom)
| |
Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury
S.P. Arold, E.L. Berry, D. Rosa, F.A. Saia, S. Kong, P.L. Wright, R.W. Clarke, D.L. Hava (Lexington, United States Of America)
| |
Inhaled calcium salts reduce expression of inflammatory mediators associated with tobacco smoke exposure to reduce airway inflammation
P.L. Wright, P. Woodman, D. Spicer, J. Kenyon, P. Okerholm, V. Russell, R.W. Clarke, D.L. Hava (Lexington, United States Of America; Slough, United Kingdom)
| |
Protection against allergen-induced airway hyperresponsiveness (AHR) by olodaterol in guinea pigs is synergistically enhanced by tiotropium
M. Smit, A. Zuidhof, S. Bos, H. Maarsingh, R. Gosens, J. Zaagsma, H. Meurs (Groningen, Netherlands)
| |
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
F. Li, C. Wiegman, J. Seiffert, P. Bhavsar, F. Chung (London, United Kingdom)
| |
Interaction of the glutamatergic and nitrergic signaling system in the airway hyperreactivity
A. Strapkova, M. Antosova (Martin, Slovakia)
| |
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
S. Kolahian, A.A. Shahbazfar, K. Ansarin, H. Tayefi, H. Ghasemi, A.H. Rashidi, M. Hanifeh (Tabriz, Islamic Republic Of Iran)
| |
Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation
Y. Riffo-Vasquez, C. Page (London, United Kingdom)
| |
Protective effect of fenspiride on bronchi in rats with COPD
N. Kuzubova, E. Lebedeva, A. Fedin, I. Dvorakovskaya (Saint Petersburg, Russian Federation)
| |
Effects of corticosteroid and montelukast treatment in inflammation in guinea pigs with chronic allergic inflammation
N. Gobbato, F. Souza, C. Prado, M. Martins, I. Tiberio, E. Leick (Sao Paulo, Brazil)
| |
Effect of low level light therapy (LLLT) on an experimental model of LPS-induced lung inflammation
A.P. Ligeiro de Oliveira, R. de Paula Vieira, J.P. Schatzmann Peron, E. Gomes, F. Mafra de Lima, M. Russo, F. Aimbire (Sao Paulo, Brazil)
| |
Effect of CCR3 inhibitors on allergic airway responses in ascaris-sensitized cynomolgus monkeys
E. Barrett, K. Rudolph, C. Royer, T. Ly, S. Boehme, K. Bacon (Albuquerque, San Diego, United States Of America)
| |
PK/PD profiles of the CXCL8 decoy protein PA401 after intravenous and intratracheal administration in saline and LPS exposed mice
T. Adage, A. Falsone, R. Doornbos, M. Bartley, A. Kungl (Graz, Austria)
| |
Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
A. Sichelstiel, A. Trompette, K. Yadava, L. P. Nicod, B. J. Marsland (Lausanne, Switzerland)
| |